Reimagine effective prevention

References: 1. Takhzyro. Prescribing information. Dyax Corp; 2023. 2. Cinryze. Prescribing information. Takeda Pharmaceuticals USA, Inc; 2023. 3. Haegarda. Prescribing information. CSL Behring LLC; 2022. 4. Orladeyo. Prescribing information. BioCryst Pharmaceuticals, Inc; 2023. 5. Banerji A, Bernstein JA, Johnston DT, et al; HELP OLE Investigators. Allergy. 2022;77(3):979-990. doi:10.1111/all.15011 6. Banerji A, Riedl MA, Bernstein JA, et al. JAMA. 2018;320(20):2108-2121. doi:10.1001/jama.2018.16773 7. Data on file, TAK743-303, Takeda Pharmaceuticals USA, Inc. 8. Riedl MA, Bernstein JA, Craig T, et al. Clin Transl Allergy. 2017;7:36. doi:10.1186/s13601-017-0172-9 9. Data on file, TAK743-098, Takeda Pharmaceuticals USA, Inc. 10. Maurer M, Lumry WR, Li HH, et al; SPRING Investigators. J Allergy Clin Immunol Pract. Published online September 18, 2023. doi:10.1016/j.jaip.2023.09.009 11. Busse PJ, Christiansen SC, Riedl MA, et al. J Allergy Clin Immunol Pract. 2021;9(1):132-150.e3. doi:10.1016/j.jaip.2020.08.046 12. Lumry WR, Weller K, Magerl M, et al; HELP Study Investigators. Allergy. 2021;76(4):1188-1198. doi:10.1111/all.14680 13. Weller K, Groffik A, Magerl M, et al. Allergy. 2012;67(10):1289-1298. doi:10.1111/all.12007 14. Weller K, Magerl M, Peveling-Oberhag A, Martus P, Staubach P, Maurer M. Allergy. 2016;71(8):1203-1209. doi:10.1111/all.12900